After a drug or medical device is approved, post-marketing surveillance is crucial for identifying any adverse events or long-term effects that may not have been evident in clinical trials. Epidemiological methods such as cohort studies and case-control studies are utilized to monitor these outcomes and ensure continued safety for the public.
